The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
January 28th 2025
The new indication for semaglutide adds to the long list of conditions that the GLP-1 receptor agonist has been approved for, and provides a new option for high-risk patients with these chronic conditions.
Twice-Yearly Subcutaneous Lenacapavir Injection for HIV Provides Favorable Quality-of-Life Outcomes
July 27th 2023Further analysis shows that 300 mg lenacapvir tablets plus an optimized background regimen can effectively reconcile a missed dose of lenacapavir injection in patients with HIV.
Read More
Early Peanut Introduction Deemed Safe to Prevent Allergy, Some Parents Unaware or Hesitant
July 26th 2023With new guidelines surrounding the introduction of peanuts to infants as young as 4 months of age, more work needs to be done to increase awareness among parents and caregivers to prevent peanut allergy at an early age.
Read More
Once-Weekly Insulin Analogue Demonstrates Promising Results for Those With Type 2 Diabetes
July 25th 2023Patients with type 2 diabetes receiving once-weekly insulin icodec were more likely to reach a hemoglobin A1C level below 7% compared to those who received once-daily insulin analogues.
Read More
Anti-Amyloid Monoclonal Antibody Drugs Continue to Show Promise Treating Alzheimer Disease
July 24th 2023New anti-amyloid monoclonal antibody drugs for Alzheimer disease have produced encouraging results in targeting the accumulation of amyloid beta plaques; however, questions remain regarding the risk-benefit profile and cost implications.
Read More